The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

BIO World Congress on Industrial Biotechnology & Bioprocessing

This year’s World Congress on Industrial Biotechnology starts today in Toronto.

A report from The Milken Institute released into the lead-up before the conference includes some interesting data:

  • Industrial biotechnology received $1.48 billion in venture investment from 2004 to 2009, compared to $1.99 billion for biofuels and $17.48 billion for therapeutic biotech plays.
  • Up to 78% of industrial biotech ventures cite “operational income” as a funding source — an impressive number of revenue-generating companies.
  • Some notable joint ventures include Metabolix joining with Archer Daniels Midland to form Telles, a plastic biorefinery; Cargill and Dow partnering on Natureworks; and DuPont’s pending offer for Danisco.

My colleague Lucas Thacker and I will be providing coverage of the conference over the next few days, so stay tuned for posts and for tweets @crossborderbio or under #WCIBB and let us know if you’re at the conference…

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 128 other followers